Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thibaut Crépin has a total of 271 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differences in RNA Binding Between Segmented and Non-Segmented Negative-Strand Virus Nucleocapsids

    by Rob W. H. Ruigrok, Allison Ballandras-Colas, Thibaut Crépin, Hélène Malet, Dan Kolakofsky

    Segmented and non-segmented negative-strand RNA viruses share the same general pathway for genome transcription, which generates messenger RNA, and genome replication which duplicates the viral RNA. These processes are performed by the viral polymerase and necessitate the viral RNA to be coated by a non-covalent polymer of nucleoproteins known as nucleocapsid. The non-segmented negative-strand RNA viruses (nsNSVs) have rigid nucleocapsids covering the entire tightly bound genome and require a phosphoprotein cofactor for proper replication and transcription by the polymerase, while the segmented negative-strand RNA viruses (sNSVs) have very flexible nucleocapsids with only few nucleotides tightly bound to each nucleoprotein, and their viral RNA genome ends are directly bound to the polymerase. We discuss here how the differences in RNA binding are likely to be crucial for proper replication and transcription in both nsNSVs and sNSVs.


  • Open Access

    Structure de la ribonucléoprotéine du virus de la grippe

    by Allison Ballandras-Colas, Alice J. Stelfox, Rob W.H. Ruigrok, Thibaut Crépin

    Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé

  • Monomeric Structure of Influenza A Virus NEP/NS2 Obtained With an Artificial Protein Highlights Conformational Plasticity

    by Alice J. Stelfox, Mélissa Bessonne, Jean-Marie Bourhis, Elisabetta Boeri Erba, Pascal Albanese, David Perez Compte, Quentin Nevers, Agathe Urvoas, Marie Valerio-Lepiniec, Philippe Minard, et al.

  • Open Access

    Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymerase

    by Mélissa Bessonne, Jessica Morel, Quentin Nevers, Julie Groutsch, Agathe Urvoas, Marie Valerio-Lepiniec, Thibaut Crépin, Philippe Minard, Bernard Delmas


  • Open Access

    Monomeric structure of influenza A virus NEP/NS2 highlights conformational plasticity

    by Alice J. Stelfox, Mélissa Bessonne, Jean-Marie Bourhis, Elisabetta Boeri Erba, Pascal Albanese, David Perez Compte, Quentin Nevers, Agathe Urvoas, Marie Valerio-Lepiniec, Philippe Minard, et al.

  • Open Access

    Influenza a virus antiparallel helical nucleocapsid-like pseudo-atomic structure

    by Florian Chenavier, Eleftherios Zarkadas, Lily-Lorette Freslon, Alice J Stelfox, Guy Schoehn, Rob W H Ruigrok, Allison Ballandras-Colas, Thibaut Crépin

    Influenza A viruses are responsible for human seasonal epidemics and severe animal pandemics with a risk of zoonotic transmission to humans. The viral segmented RNA genome is encapsidated by nucleoproteins (NP) and attached to the heterotrimeric polymerase, forming the viral ribonucleoproteins (vRNPs). Flexible helical vRNPs are central for viral transcription and replication. In this study, we present an advanced biological tool, the antiparallel helical RNP-like complex, assembled from recombinant N-terminally truncated NP and short synthetic RNA. The 3.0 Å cryo-electron microscopy structure details for the first time the whole RNA pathway across NP as well as NP-NP interactions that drive the antiparallel helical assembly accommodating major and minor grooves. Our findings show that the surface of the protein can harbour several conformations of the RNA, confirming that the number of nucleobases that binds to NP is not fixed, but ranges probably between 20 and 24. Taking all together, our data provide details to further understand the genome encapsidation and explain the inherent flexibility of influenza A virus vRNPs.


  • Open Access

    Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymerase

    by Mélissa Bessonne, Jessica Morel, Quentin Nevers, Agathe Urvoas, Marie Valerio-Lepiniec, Thibaut Crépin, Philippe Minard, Bernard Delmas

    Seasonal epidemics and pandemics caused by influenza A viruses still represent a main public health burden in the world. Influenza viruses replicate and transcribe their genome in the nucleus of the infected cells, two functions that are supported by the viral RNA-dependent RNA-polymerase (FluPol) through extensive structural rearrangements and differential interactions with host cell factors. To get insights into its functioning, we screened a phage-display library of biosynthetic proteins (named αReps and build on a rigid alpha-helicoidal HEAT-like scaffold) against the structurally invariant FluPol core and several flexibly-linked domains of the FluPol PB2 subunit. Several αReps specific of the cap binding domain [CBD], the 627-domain and the NLS domain of the PB2 FluPol subunit displayed FluPol inhibitory and virus neutralization activities when transiently expressed in the cytosol. Furthermore, intracellular ectopic inducible expression of the αReps C3 and F3 (specific of the CBD and the 627-domain, respectively) in influenza virus permissive cells blocked transcription and multiplication of viruses representative of the H1N1, H3N2 and H7N1 subtypes, even when induced at late times post-infection. A synergic inhibitory effect on FluPol activity and virus multiplication was evidenced when the two αReps were covalently linked. These results suggest that i) interfering with FluPol structural rearrangements that are concomitant to its various activities may represent a promising strategy to block virus multiplication and to design new types of antivirals such as dual binders targeting distant sites on FluPol and ii) the 627-domain could be efficiently targeted to design influenza antivirals. Author Summary The influenza virus RNA-polymerase (FluPol) ensures genome transcription and replication in the nucleus of the infected cells. To select ligands able to interfere with FluPol functions, we screened a library of phages encoding biosynthetic proteins (named αReps) for binding to FluPol subunits and domains. When expressed intracellularly, several of them display efficient FluPol blocking and virus neutralizing activities. αReps C3 and F3 assembled through covalent linkages blocked FluPol activity more efficiently than their precursors. These αReps impaired multiplication of H1N1, H3N2 and H7N1 viruses, showing that their binding sites may constitute effective targets for new antiviral development.


  • Open Access

    Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase core

    by Mélissa Bessonne, Jessica Morel, Quentin Nevers, Bruno Da Costa, Allison Ballandras-Colas, Florian Chenavier, Magali Grange, Alain Roussel, Thibaut Crépin, Bernard Delmas

    Influenza viruses transcribe and replicate their genome in the nucleus of the infected cells, two functions that are supported by the viral RNA-dependent RNA-polymerase (FluPol). FluPol displays structural flexibility related to distinct functional states, from an inactive form to conformations competent for replication and transcription. FluPol machinery is constituted by a structurally-invariant core comprising the PB1 subunit stabilized with PA and PB2 domains, whereas the PA endonuclease and PB2 C-domains can pack in different configurations around the core. To get insights into the functioning of FluPol, we selected single-domain nanobodies (VHHs) specific of the influenza A FluPol core. When expressed intracellularly, some of them exhibited inhibitory activity on type A FluPol, but not on the type B one. The most potent VHH (VHH16) binds PA and the PA-PB1 dimer with an affinity below the nanomolar range. Ectopic intracellular expression of VHH16 in virus permissive cells blocks multiplication of different influenza A subtypes, even when induced at late times post-infection. VHH16 was found to interfere with the transport of the PA-PB1 dimer to the nucleus, without affecting its handling by the importin β RanBP5 and subsequent steps in FluPol assembly. Using FluPol mutants selected after passaging in VHH16-expressing cells, we identified the VHH16 binding site at the interface formed by PA residues with the N-terminus of PB1, overlapping or close to binding sites of two host proteins, ANP32A and RNA-polymerase II RPB1 subunit which are critical for virus replication and transcription, respectively. These data suggest that the VHH16 neutralization is likely due to several activities, altering the import of the PA-PB1 dimer into the nucleus as well as inhibiting specifically virus transcription and replication. Thus, the VHH16 binding site represents a new Achilles’ heel for FluPol and as such, a potential target for antiviral development.


  • Open Access

    Structural Impact of the Interaction of the Influenza A Virus Nucleoprotein with Genomic RNA Segments

    by Erwan Quignon, Damien Ferhadian, Antoine Hache, Valérie Vivet-Boudou, Catherine Isel, Anne Printz-Schweigert, Amélie Donchet, Thibaut Crépin, Roland Marquet

    Influenza A viruses (IAVs) possess a segmented genome consisting of eight viral RNAs (vRNAs) associated with multiple copies of viral nucleoprotein (NP) and a viral polymerase complex. Despite the crucial role of RNA structure in IAV replication, the impact of NP binding on vRNA structure is not well understood. In this study, we employed SHAPE chemical probing to compare the structure of NS and M vRNAs of WSN IAV in various states: before the addition of NP, in complex with NP, and after the removal of NP. Comparison of the RNA structures before the addition of NP and after its removal reveals that NP, while introducing limited changes, remodels local structures in both vRNAs and long-range interactions in the NS vRNA, suggesting a potentially biologically relevant RNA chaperone activity. In contrast, NP significantly alters the structure of vRNAs in vRNA/NP complexes, though incorporating experimental data into RNA secondary structure prediction proved challenging. Finally, our results suggest that NP not only binds single-stranded RNA but also helices with interruptions, such as bulges or small internal loops, with a preference for G-poor and C/U-rich regions.


  • Open Access

    Cryo-EM structure of influenza helical nucleocapsid reveals NP-NP and NP-RNA interactions as a model for the genome encapsidation

    by Florian Chenavier, Leandro F. Estrozi, Jean-Marie Teulon, Eleftherios Zarkadas, Lily-Lorette Freslon, Jean-Luc Pellequer, Rob W. H. Ruigrok, Guy Schoehn, Allison Ballandras-Colas, Thibaut Crépin

    Influenza virus genome encapsidation is essential for the formation of a helical viral ribonucleoprotein (vRNP) complex composed of nucleoproteins (NP), the trimeric polymerase, and the viral genome. Although low-resolution vRNP structures are available, it remains unclear how the viral RNA is encapsidated and how NPs assemble into the helical filament specific of influenza vRNPs. In this study, we established a biological tool, the RNP-like particles assembled from recombinant influenza A virus NP and synthetic RNA, and we present the first subnanometric cryo–electron microscopy structure of the helical NP-RNA complex (8.7 to 5.3 Å). The helical RNP-like structure reveals a parallel double-stranded conformation, allowing the visualization of NP-NP and NP-RNA interactions. The RNA, located at the interface of neighboring NP protomers, interacts with conserved residues previously described as essential for the NP-RNA interaction. The NP undergoes conformational changes to enable RNA binding and helix formation. Together, our findings provide relevant insights for understanding the mechanism for influenza genome encapsidation.